Boundless Bio, Inc. EBITDA for the Trailing 12 Months (TTM) ending December 31, 2024: USD -72.18 M

Boundless Bio, Inc. EBITDA is USD -72.18 M for the Trailing 12 Months (TTM) ending December 31, 2024, a 34.07% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.
  • Boundless Bio, Inc. EBITDA for the Trailing 12 Months (TTM) ending December 31, 2023 was USD -53.84 M.
Key Data
Date EBITDA Net Income EPS (Diluted) Shares (Diluted, Weighted)